Analyst Ratings for Supernus Pharmaceuticals Inc. (SUPN)Updated: 2017-07-27
An average rating of Overweight has been given to Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) by analysts covering the stock. SUPN had previously received a consensus rating of Buy a month ago.
Of the 7 analysts covering the stock, 5 gave it a buy rating, 0 issued an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.
A number of analysts gave price targets for SUPN. The most optimistic price target was 51, implying potential capital gains of 24.09 percent. The most pessimistic analyst gave a price target of 40, which equates to a potential downside of -2.68 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Analysts have revised their earnings estimates downwards for this quarter, by about -7.56 percent on average, compared to last month. That number becomes -23.79 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised downwards by -7.71 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -21.32 percent in FY estimates.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 3 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 3 analysts decreased their estimates.
SUPN has an estimated earnings growth rate of -46.43 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of SUPN is -0.48.
In the last 52-weeks, SUPN has achieved a high of 44.95 and a low of 17.25. Today's price is 138.26 percent above the 52-week low, and 8.57 percent lower than its 52-week high. SUPN has a price/earnings ratio of 22.48. Investors typically compare the P/E ratio to a company's peers in the industry. The SUPN value stock report compares SUPN to some of its peers using value stock charts. The market cap of SUPN is $2.12 billion. SUPN's next earnings release will be on 0000-00-00, which is days away.